Hualan Biological Engineering, Inc. News

Earnings Miss: Here's What Hualan Biological Engineering Inc. (SZSE:002007) Analysts Are Forecasting For Next Year

Simply Wall StOct 31 18:19 ET

Hualan Biological Engineering, Inc.: Third-quarter report of 2024.

SZSIOct 29 12:00 ET · Announcements

hualan biological engineering, inc. (002007.SZ) released its performance for the first three quarters, with a net income of 0.924 billion yuan, a year-on-year decrease of 13.46%.

hualan biological engineering, inc. (002007.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...

Zhitong FinanceOct 29 11:20 ET

Express News | Hualan Biological Engineering Q3 Net Profit Down 10.6% Y/Y

ReutersOct 29 06:42 ET

Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Simply Wall StOct 16 18:25 ET

Hualan Biological Engineering Inc.'s (SZSE:002007) Intrinsic Value Is Potentially 89% Above Its Share Price

Simply Wall StSep 10 18:18 ET

Hualan Biology: 2024 Semi-Annual Report

SZSIAug 29 12:00 ET · Announcements

Hualan Biology: Summary of the 2024 Semi-Annual Report

SZSIAug 29 12:00 ET · Announcements

hualan biological engineering, inc. (002007.SZ): net income of 0.44 billion yuan in the first half of the year, a year-on-year decrease of 16.42%

GeLongHui August 29th | Hualan Biological Engineering, Inc. (002007.SZ) released its semi-annual report for 2024, with a reported revenue of 1.653 billion yuan for the reporting period, a year-on-year increase of 4.26%; net income attributable to the shareholders of the listed company was 0.44 billion yuan, a year-on-year decrease of 16.42%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.363 billion yuan, a year-on-year decrease of 8.73%; basic earnings per share was 0.2406 yuan.

Gelonghui FinanceAug 29 05:04 ET

Express News | Hualan Biological Engineering H1 Net Profit Down 16.4% Y/Y

ReutersAug 29 04:57 ET

Hualan Biological to Set Up Plasma Stations in Two Chinese Counties

MT NewswiresAug 26 02:59 ET

Hualan Biological Engineering Inc.'s (SZSE:002007) Market Cap Dropped CN¥1.3b Last Week; Individual Investors Bore the Brunt

Simply Wall StAug 22 20:06 ET

Sinolink Securities: Further consolidation of the blood product industry through external mergers and acquisitions and product diversification.

Referring to the development process of leading overseas blood product companies, external mergers and acquisitions, new product development, and efficiency improvement are three important development routes. In recent years, domestic blood product industry mergers and acquisitions have continued to take place, and the concentration of the industry has shown a further upward trend.

Zhitong FinanceAug 21 04:44 ET

Guolian Securities: Supply and demand boost, domestic blood product penetration rate is expected to continue to rise.

The per capita use of blood products in China is less than one-fourth that of developed countries such as the USA, and the demand is showing an increasing trend. As the supply of plasma increases and clinical awareness improves in the future, China's penetration rate is expected to continue to improve.

Zhitong FinanceAug 13 02:20 ET

Hualan Biological Engineering (SZSE:002007) Could Easily Take On More Debt

Simply Wall StAug 5 03:29 ET

Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E No Reason For Excitement

Simply Wall StJul 15 19:54 ET

Hualan Biological Engineering, Inc. (002007.SZ): As of July 10th, the company has more than 1.5 million investors.

As of July 10, 2024, hualan biological engineering, inc. had over 1.5 million investors on its investor interaction platform.

Gelonghui FinanceJul 12 03:08 ET

GLE Announcements Selection: Zhuhai Guanyu Plans to Invest Not More Than 2 Billion Yuan in Malaysia Guanyu New Energy Project; Zijin Mining Group: Net Income Is Expected to Increase by About 41%-50% YoY in the First Half of the Year.

Investment project: Zhuhai Guanyu (688772.SH): plans to invest no more than 2 billion yuan to build new energy projects for Guanyu batteries in Malaysia; Tianyuan Group (002386.SZ): Haifeng and Rui plan to invest 0.136 billion yuan to build an optimized ion membrane electrolysis tank project for chlor-alkali plant; Tianyuan Group (002386.SZ): Haifeng and Tai plan to invest 73.8971 million yuan in the quality improvement optimization technology transformation project for titanium dioxide; Tianyuan Group (002386.SZ): Haifeng and Rui plan to invest 72.61 million yuan to build a 40MW/80WWh user-side electrochemical energy storage power station.

Gelonghui FinanceJul 8 10:55 ET

Express News | Hualan Biological Says Chairman, Senior Execs Plan to Increase Holdings in the Company by 1.2-2.4 Mln Shares Within Six Months

ReutersJul 8 05:37 ET

Hualan Biological Engineering Inc. (SZSE:002007) Stock Goes Ex-Dividend In Just Three Days

Simply Wall StJun 9 21:39 ET